Don’t miss these top stories:
Get a COVID vaccine, and get a free Krispy Kreme doughnut every single day this year
The sweet vaccination push sparked some backlash, as critics claim it promotes obesity
A quarter of Americans have recently witnessed someone blame Asian people for COVID-19
The new survey was conducted after the shooting deaths of six Asian women in the Atlanta area.
Rents are still dropping in some parts of the country — but these tenants are missing out
Nationally, the rental market is showing signs of improvement.
‘My pulse rate had shot up to 120 as I gasped my way into the ER’: Italy resumes AstraZeneca vaccine, and tightens lockdown
More than half of Italy’s regions are now in the ‘red zone,’ just one year after the country effectively shut down.
IRS: More $1,400 stimulus payments are coming — so check your mail
Another wave of $1,400 stimulus payments rolling out this week --- and this time, many are coming as paper checks or pre-paid debit cards, the Internal Revenue Service announced Monday.
Existing-home sales fall as inventory remains a challenge for buyers
Analysts say that weather-related disruptions to the economy in February likely had an impact on home sales as well.
You’re vaccinated. Can you finally take a vacation?
Many countries — including most of Western Europe— still aren’t open to U.S. tourists.
7 things NOT to buy with your $1,400 stimulus check
'It would be sad and painful to see people end up losing this money that was designed to prop up the economy and get us out of COVID-induced recession.'
Elsewhere on MarketWatch
Democrats, Republicans divided over Washington, D.C., statehood in House hearing
Democrats and Republicans sparred Monday over statehood for Washington, D.C., with proponents saying residents were due full voting rights and critics calling it a partisan power grab and arguing the city’s unique status raised constitutional hurdles.
AstraZeneca’s new COVID-19 vaccine trial data will give the shot a U.S. boost
The COVID-19 vaccine of the U.K.-Swedish pharmaceuticals group AstraZeneca has shown robust results in its U.S. trial, the company said on Monday.
Bitcoin, crypto investors will be watching these 5 questions facing the Biden administration
The fate of the dizzying rally in crypto assets could depend greatly on the Biden administration's regulatory stance to the burgeoning crypto economy
Economists say inflation risks highest in two decades and could force Fed to raise interest rates in 2022
Federal Reserve leaders keep saying they don't plan to raise rock-bottom U.S. interest rates for several years, but a growing number of economists think a speedier recovery and high inflation will force the central bank to act more quickly.